Historical record - last NADAC effective date: 7/17/2024

Product Information

SELEGILINE HCL 5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.6101 per EA under NDC 60505343808. Its NADAC has been published 560 times since Nov 28, 2013.

FDA first approved this application on Jun 6, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SELEGILINE HCL 5 MG TABLET

Selegiline Hydrochloride
$0.6101per EA

Strength

5 mg/1

Manufacturer

Apotex Corp.

NDC

60505343808

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

7/17/2024

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074871

FDA Approved

6/6/1997

TE Code

AB

On Market Since

7/6/1997

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG TABLET has been published 560 times since Nov 28, 2013, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6101 per EA
All-time high$2.1399 (Jul 16, 2014)
All-time low$0.6101 (Jul 17, 2024)
Median price$1.1426
Average price$1.2070
Largest weekly change+42.1% (Oct 18, 2017)
Weeks tracked560
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-33.0%

5Y

-43.6%

All

-63.8%

Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by Apotex Corp., is $0.6101 per EA (NDC 60505343808), effective Aug 14, 2024.

How has the price of SELEGILINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 63.8%. It has been tracked across 560 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $2.1399 (Jul 16, 2014), with a median of $1.1426 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SELEGILINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SELEGILINE HCL 5 MG TABLET?

SELEGILINE HCL 5 MG TABLET (NDC 60505343808) is labeled by Apotex Corp., and CMS classifies it as a generic product.